Corona vaccine from the age of 12 – STIKO makes a recommendation

Corona vaccines for children and adolescents have been approved since June. The recommendation of the Standing Vaccination Commission (STIKO) was not forthcoming. The reason for this: too few studies on corona vaccination among younger people.

The vaccine is not only approved for children and adolescents in Europe, vaccinations for children and adolescents are also already underway in the USA. New results and data from America prompt the Standing Vaccination Commission to make a comprehensive recommendation.

STIKO: New data speak in favor of vaccination for children

Due to a lack of study results and data on corona vaccination in children and adolescents, the STIKO recommendation initially only referred to children with previous illnesses such as  obesity , chronic lung diseases,  diabetes  mellitus, heart defects and  trisomy 21 . They are all associated with an increased risk of a severe course of COVID-19.

New data, especially from the American vaccination program, enable STIKO to better and more reliably assess vaccinations for children and young people aged twelve and over.

Serious side effects, such as heart muscle inflammation, have not been observed in children and adolescents to date. Rather, there is also a risk for this age group of  contracting long-COVID  and the long-term consequences of the corona vaccination.

STIKO also emphasizes that in the context of a fourth wave of infection, which could be triggered by the Delta variant, there is a higher risk of COVID-19 disease for children and adolescents.

The vaccination recommendation means direct protection of the vaccinated children and young people from the disease itself and possible consequences. However, vaccination is not a prerequisite for social participation, such as going to school.

If parents are unsure about vaccination, it is recommended to seek medical advice.

Children often transmit Corona in the home

A study from Canada shows that children are more often responsible for corona infections in households than adults.

Since children and adolescents were   only rarely infected with  COVID-19 at the beginning of the pandemic  and the disease often took a symptom-free or mild course, the transmission rate was initially assumed to be low.

The first infection occurred in a child in around 6,000 households. The largest proportion was made up of 9 to 13 year olds (30 percent) and 14 to 17 year olds (38 percent). Infants and young children still make a high contribution: the youngest children are the main carriers at 43 percent – more often than teenagers, who have often been classified as silent carriers.

However, the study was carried out before schools and kindergartens were opened. The extent to which this factor is to be evaluated still needs to be investigated in the future.

Vaccine manufacturers such as  Moderna  and BioNTech/Pfizer are already testing the vaccine on younger children, and the results so far have been promising.

That is why there is no corona vaccine specifically for children

The safety of the study participants is the top priority in every clinical study – this is especially true for young people. Therefore, for ethical reasons, studies with new active ingredients, such as the corona vaccines, are usually not carried out on children. This also applies to pregnant and breastfeeding women.

Normally, an active substance or a vaccine can only be tested on children and adolescents if there are already positive results from studies with adults. In most cases, such studies only take place when the vaccine or drug has already been approved for adults or is about to be approved.

This is exactly the case with the corona vaccines that are already available – due to the global importance of the pandemic, the studies on safety in children are already taking place.

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *